The aim of this study was to assess computed-tomography histogram analysis (CTHA) as prognostic and predictive factor in platinum-refractory non-small cell lung carcinoma (NSCLC) treated with immune checkpoint inhibitor Nivolumab.
Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: A multicentre retrospective study
Ravanelli, MarcoConceptualization
;Agazzi, Giorgio MariaFormal Analysis
;Roca, ElisaConceptualization
;Rondi, PaoloFormal Analysis
;Baggi, AliceFormal Analysis
;Botti, Camilla;Maroldi, Roberto;Berruti, Alfredo;Farina, Davide
2019-01-01
Abstract
The aim of this study was to assess computed-tomography histogram analysis (CTHA) as prognostic and predictive factor in platinum-refractory non-small cell lung carcinoma (NSCLC) treated with immune checkpoint inhibitor Nivolumab.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
